Menu Close ✕

About
Technology
- Overview
- TCR-NK
Pipeline
Investors
Careers & Culture
Contact

Zelluna – News – MedWatch: Ultimovacs merges with Zelluna Immunotherapy

MedWatch: Ultimovacs merges with Zelluna Immunotherapy

https://medwatch.no/nyheter/legemidler_biotek/article17745281.ece

Print this article

27, February, 2025

E-mail:

post@zelluna.com ir@zelluna.com bd@zelluna.com careers@zelluna.com

Technology

Technology
TCR-NK

Zelluna

About Zelluna
Management
Scientific Advisory Board
Contact us

Investors

Share information
Financial reports
Investor relations contacts
News

Copyright © Zelluna ASA 2025 | Privacy statement